Studies have shown that slowing down the progression of Parkinson’s adds significant quality-adjusted life years and cost savings.
“Medicare Advantage (MA) plans, which focus on complex patients, are now a viable place for a 'prevention play'. The exciting part of Medicare Advantages is that it is enabling companies with these technologies to get into patients’ homes and really drive better outcomes."